Literature DB >> 1741754

pH-dependency of basic ligand binding to alpha 1-acid glycoprotein (orosomucoid).

S Urien1, F Brée, B Testa, J P Tillement.   

Abstract

The binding interactions of a series of basic ligands with alpha 1-acid glycoprotein (AAG) were examined as a function of pH. The binding to AAG increased with increasing pH, and the binding data were satisfactorily fitted to a model that incorporates the effect of pH and discriminates the association constants of neutral (non-protonated) and protonated forms of ligands. It was shown that ligands in the neutral form have a markedly higher affinity for AAG than the protonated forms, resulting in a concomitant decrease in the pKa of bound ligands. The u.v.-visible difference spectra generated upon binding of a representative ligand to AAG also showed that there was a contribution to the binding arising from the deprotonation of the ligand. It is suggested that all tested ligands bind similarly to AAG and that hydrophobic interactions dominate high-affinity binding to AAG.

Mesh:

Substances:

Year:  1991        PMID: 1741754      PMCID: PMC1130632          DOI: 10.1042/bj2800277

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein.

Authors:  W R Ravis; D L Parsons; S J Wang
Journal:  J Pharm Pharmacol       Date:  1988-07       Impact factor: 3.765

Review 2.  Drug binding to human alpha-1-acid glycoprotein in health and disease.

Authors:  J M Kremer; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

3.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 4.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

5.  The binding of aryl carboxylic acid derivatives to human serum albumin--a structure-activity study.

Authors:  S Urien; P D'Athis; J P Tillement
Journal:  Biochem Pharmacol       Date:  1984-07-15       Impact factor: 5.858

6.  Fluorescence quenching of human orosomucoid. Accessibility to drugs and small quenching agents.

Authors:  M L Friedman; K T Schlueter; T L Kirley; H B Halsall
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

7.  Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein.

Authors:  S Urien; E Albengres; R Zini; J P Tillement
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

8.  Steroid-protein interactions. XXXIV. Chemical modification of alpha1-acid glycoprotein for characterization of the progesterone binding site.

Authors:  T Kute; U Westphal
Journal:  Biochim Biophys Acta       Date:  1976-01-20

9.  Phencyclidine blood protein binding: influence of protein, pH and species.

Authors:  S M Owens; M Mayersohn; J R Woodworth
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

10.  Gallopamil binding to human serum proteins.

Authors:  D R Rutledge; J A Pieper
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more
  11 in total

1.  Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery.

Authors:  Yin Cheong Wong; Shuai Qian; Zhong Zuo
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

2.  pH dependent binding of ligands to serum lipoproteins.

Authors:  N Simon; E Dailly; P Jolliet; J P Tillement; S Urien
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

3.  Mechanism of ligand binding to alpha 1-acid glycoprotein (orosomucoid): correlated thermodynamic factors and molecular parameters of polarity.

Authors:  S Urien; Y Giroud; R S Tsai; P A Carrupt; F Brée; B Testa; J P Tillement
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

4.  Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein.

Authors:  F Herve; E Gomas; J C Duche; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

5.  pH-dependence of warfarin binding to alpha 1-acid glycoprotein (orosomucoid).

Authors:  S Urien; F Brée; B Testa; J P Tillement
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

6.  Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry.

Authors:  Suzan M Semaan; Xu Wang; Alan G Marshall; Qing-Xiang Amy Sang
Journal:  J Cancer       Date:  2012-06-21       Impact factor: 4.207

7.  The Long Pentraxin PTX3 Is of Major Importance Among Acute Phase Proteins in Chickens.

Authors:  Nina B Burkhardt; Susanne Röll; Anke Staudt; Daniel Elleder; Sonja Härtle; Taiana Costa; Andreas Alber; Mark P Stevens; Lonneke Vervelde; Benjamin Schusser; Bernd Kaspers
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

8.  Hypothesis: Potentially Systemic Impacts of Elevated CO2 on the Human Proteome and Health.

Authors:  Carlos M Duarte; Łukasz Jaremko; Mariusz Jaremko
Journal:  Front Public Health       Date:  2020-11-16

Review 9.  Stat3 and the inflammation/acute phase response in involution and breast cancer.

Authors:  Sara Pensa; Christine J Watson; Valeria Poli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-05-08       Impact factor: 2.673

10.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.